Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:
“Great Keynote address highlighting the history of PD-1/PD-L1 inhibitors at the 2025 The New York Academy of Sciences Frontiers in Cancer Immunotherapy Symposium by Dr. Antoni Ribas of UCLA.”
